Latest Ratios: P/E Ratio -2.4x · EV/EBITDA N/A · ROE -67.4%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $171M | $275M | $120M | $162M | $209M | — | — | — |
| Enterprise Value | $127M | $231M | $89M | $101M | $52M | — | — | — |
| P/E Ratio → | -2.38 | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — |
| P/B Ratio | 0.71 | 1.86 | 1.01 | 1.49 | 1.16 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -67.4% | -67.4% | -79.3% | -54.6% | -44.2% | -38.2% | -27.7% | -34.8% |
| ROA | -55.2% | -55.2% | -61.2% | -43.6% | -38.3% | -35.4% | -25.5% | -32.1% |
| ROIC | -73.2% | -73.2% | -108.1% | -181.2% | -453.1% | -20853.1% | -756.9% | — |
| ROCE | -63.4% | -63.4% | -75.3% | -52.3% | -41.2% | -37.9% | -27.5% | -35.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.12 | 0.12 | 0.16 | 0.19 | 0.14 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.30 | -0.26 | -0.56 | -0.88 | -1.00 | -1.00 | -0.90 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — |
Net cash position: cash ($61M) exceeds total debt ($17M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.94 | 11.94 | 7.41 | 6.43 | 9.88 | 13.56 | 12.31 | 11.58 |
| Quick Ratio | 11.94 | 11.94 | 7.41 | 6.43 | 9.88 | 13.56 | 12.31 | 11.58 |
| Cash Ratio | 11.74 | 11.74 | 7.20 | 6.30 | 9.65 | 12.88 | 11.67 | 10.71 |
| Asset Turnover | — | — | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $42M | $32M | $24M | $16M | $22M | $22M | $22M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PEPG stock.
PepGen Inc.'s current P/E ratio is -2.4x. This places it at the 50th percentile of its historical range.
PepGen Inc.'s return on equity (ROE) is -67.4%. The historical average is -49.4%.
Based on historical data, PepGen Inc. is trading at a P/E of -2.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Key Metrics
Top Statement Risk
Shrinking cash against sustained losses
Metrics are mathematically derived from official filings.
Book Value Discount Reflects Cash Erosion
Based on reported figures, PEPG trades at a P/B of 0.71 with a negative P/E of -1.17, while the market appears to price the equity below book as cash declines toward $22.8M in 2026Q2.
A sub-1.0 price-to-book ratio with negative earnings suggests the market is discounting book value, which is weighted toward cash that is being consumed each quarter rather than toward productive assets. Earnings-based multiples such as P/E are not meaningful here because net losses are negative, so valuation rests on balance sheet value and the durability of remaining cash. Investors should monitor whether the discount narrows or widens as cash runway shortens, since the gap between book value and market value may largely reflect expected future dilution or capital raises that the reported figures cannot confirm.
Persistently Negative Returns on Capital
As reported in financial statements, PEPG's ROIC ranged from -13.4% to -30.5% across ten quarters, with ROE moving between -11.8% and -28.7%, indicating no sustained improvement in capital efficiency.
Negative ROIC and ROE across all ten quarters indicate that invested capital and equity are being eroded rather than compounded, consistent with an R&D-stage business that has not yet generated revenue. The deepest deterioration occurred in 2025Q1 through 2025Q3, with partial moderation thereafter, though returns remain well below zero. Because the denominator of invested capital is shrinking as cash is burned, the ratios may appear less negative over time without reflecting any genuine operating improvement.
Headline Current Ratio Masks Thin Cash
According to recent SEC filings, PEPG's current ratio of 13.36 in 2026Q2 appears strong, yet cash of $22.8M against quarterly free cash outflows of roughly $15.8M to $24.2M implies a limited near-term runway.
The current ratio of 13.36 is high in isolation, but it is driven by current assets that are predominantly cash and short-term holdings relative to a small liability base, so it overstates real financial flexibility. Against quarterly burn of similar magnitude to the cash balance, the company appears to have less than one quarter of coverage from cash alone on a simple basis. The quick ratio equals the current ratio here, which is consistent with minimal inventory, but this does not offset the dependence on external financing that the reported figures suggest.
Low Debt Offers Little Comfort
Based on reported figures, PEPG's D/E ratio of 0.13 in 2026Q2 remains low, but it rose from 0.11 in 2025Q3 as equity contracted rather than as borrowing expanded, and interest coverage is not meaningful given no operating earnings.
Low leverage here reflects limited borrowing capacity and an equity base that is shrinking through accumulated losses, so the ratio improves on its own only in appearance. With operating income negative, interest coverage and debt-to-EBITDA cannot be interpreted in the usual way, and the absence of meaningful coverage metrics should be read as a constraint rather than a sign of safety. Refinancing or covenant risk cannot be assessed from the supplied data beyond noting that the debt base is small relative to the operating burn.
Misapplied Metric: Current Ratio
The current ratio is most commonly misapplied to pre-revenue biotechnology companies, where it appears to signal solvency while obscuring how quickly cash is consumed relative to the reported balance.
For a company like PEPG, the current ratio gives a comforting reading driven by cash that is steadily being consumed by operating losses, so it captures the balance at a point in time rather than the trajectory. A more informative alternative is cash runway, calculated as cash and equivalents divided by average quarterly free cash outflow, which yields a figure closer to one quarter on the reported numbers. Analysts should also treat stock-based compensation add-backs as a real economic cost when judging burn, since they represent dilution borne by existing shareholders.